Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Inhalation of CO2 after a traumatic experience enhances fear memory in mice

The inhalation of carbon dioxide (CO2) by mice a few hours after they formed a new fearful memory makes that memory stronger, so that the mice show more distress when they are prompted to 'retrieve' (ie, recall) it.

8 Nov 2021

Milestone study uncovers genetic risk factors for spine osteoarthritis

Scientists from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed), contributing as part of the 'Genetics of Osteoarthritis (GO)' consortium to the world's largest study of over 800,000 individuals, have identified genetic risk factors - variants associated with SOX5 and CHST3 genes, key regulators of the development of the intervertebral discs, to be implicated in spine osteoarthritis (OA).

8 Nov 2021

High sitting time may increase depressive symptoms and anxiety

As people adhered to stay-at-home orders or self-isolated during the early months of the COVID-19 outbreak, daily commutes turned into shuffles between the bedroom and the living room. Clicking Zoom links erased time spent walking to meeting rooms, and Netflix spilled into time otherwise dedicated to the gym.

8 Nov 2021

Study finds significant increase in cannabis use disorder during pregnancy

As more states legalize cannabis (now 37) for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.

3 Nov 2021

Study shows aberrant changes over time in the brains of people with bipolar disorder

Bipolar disorder (BD) is a debilitating psychiatric disorder characterized by fluctuating periods of depression and mania.

3 Nov 2021

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

In a pilot human study, researchers from the University of Minnesota Medical School and Massachusetts General Hospital show it is possible to improve specific human brain functions related to self-control and mental flexibility by merging artificial intelligence with targeted electrical brain stimulation.

1 Nov 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

The National Institute on Aging of the National Institutes of Health has awarded researchers at Washington University School of Medicine in St. Louis a five-year, $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic's cognitive and emotional effects on older adults.

30 Oct 2021

Maternal vitamin D deficiency associated with higher risk of ASD in offspring

Maternal vitamin D deficiency during pregnancy was associated with 44% increased risk of ASD in the offspring when compared to mothers who had sufficient levels of vitamin D during pregnancy.

29 Oct 2021

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

Magnus Medical, Inc., a medical device company, today announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology designed to treat major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments.

29 Oct 2021

'Theta activity' in the brain found to be divergent for people with mental health conditions

A new review of current literature, conducted by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, has found that irregular responses in the brain to challenging tasks and mistakes could be key to understanding common links between abnormal behaviors in a range of mental illness and cognitive disorders.

28 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

Psychiatry News and Research

Further Reading

Inhalation of CO2 after a traumatic experience enhances fear memory in mice

Milestone study uncovers genetic risk factors for spine osteoarthritis

High sitting time may increase depressive symptoms and anxiety

Study finds significant increase in cannabis use disorder during pregnancy

Study shows aberrant changes over time in the brains of people with bipolar disorder

Merging AI with targeted electrical brain stimulation to improve specific human brain functions

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

Maternal vitamin D deficiency associated with higher risk of ASD in offspring

Magnus Medical receives FDA's Breakthrough Device Designation for rapid-acting technology to treat major depression

'Theta activity' in the brain found to be divergent for people with mental health conditions

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

People with psychotic disorders at higher risk of hospitalization, death from infectious diseases

Repeated dopamine release in the brain plays a key role in infant social development

Less physical activity and more screen time impact children's mental health during the pandemic

DOD funds first human trial of a device to enhance the natural brain cleansing system

Understaffed state psychiatric facilities leave mental health patients in limbo

Men’s emotions fluctuate to the same extent as that of women

Study looks at effectiveness and ethics of financial incentives for low-risk clinical trials

U of M Udall Center receives $11.3 million grant to continue research on deep brain stimulation for Parkinson’s disease

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News